- Home
- MGTX
MGTX
MeiraGTx Holdings plc
as 11-22-2024 4:00pm EST
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $23.50 | AVG Volume (30 days): | 354.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.85 - $7.60 | Next Earning Date: | 11-13-2024 |
| Revenue: | $13,929,000 | Revenue Growth: | 108.24% |
| Revenue Growth (this year): | -69.14% | Revenue Growth (next year): | 5284.51% |
Latest MeiraGTx Holdings plc News
MGTX Breaking Stock News: Dive into MGTX Ticker-Specific Updates for Smart Investing
Simply Wall St.
9 days ago
MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Zacks
11 days ago
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates
GlobeNewswire
11 days ago
MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates
GlobeNewswire
a month ago
MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress
Simply Wall St.
a month ago
High Growth Tech Stocks to Watch in October 2024
Clinical Trials Arena
a month ago
MeiraGTx’s Parkinson’s gene therapy shows promise in Phase I/II study
Zacks
a month ago
MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study
TipRanks
a month ago
MeiraGTx Holdings Reports Promising Parkinson’s Therapy Results
Compare MGTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MGTX MeiraGTx Holdings plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.